about
Emerin-prelamin A interplay in human fibroblastsDysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibitionAltered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiencyTreatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative studyMuscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organizationChondrogenic differentiation of bone marrow concentrate grown onto a hylauronan scaffold: rationale for its use in the treatment of cartilage lesions.Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamicsAutophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment.The empowerment of translational research: lessons from laminopathies.All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.Prelamin A processing and heterochromatin dynamics in laminopathies.Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome.Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathyCollagen VI myopathies: from the animal model to the clinical trial.Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathiesConcentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells.Lamin A/C sustains PcG protein architecture, maintaining transcriptional repression at target genes.The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA.Programmed cell death in 2',3'-dideoxycytidine-resistant human monoblastoid U937 cells.Lineage-related susceptibility of human hemopoietic cell lines to apoptosis.Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatmentPrelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle.Altered pre-lamin A processing is a common mechanism leading to lipodystrophy.Mitochondrial respiratory chain Complex I defects in Fanconi anemia complementation group A.Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency.Rapid and efficient magnetization of mesenchymal stem cells by dendrimer-functionalized magnetic nanoparticles.Prelamin A is involved in early steps of muscle differentiation.Mesenchymal stem cells from preterm to term newborns undergo a significant switch from anaerobic glycolysis to the oxidative phosphorylation.Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing.Elevated TGF β2 serum levels in Emery-Dreifuss muscular dystrophy: implications for myocyte and tenocyte differentiation and fibrogenic processes.Pre-Lamin A processing is linked to heterochromatin organization.Lamins and bone disorders: current understanding and perspectives.Altered lipid metabolism could drive the bone marrow failure in fanconi anaemiaMuscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutationOct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophyOsteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclastsUltrastructural defects of collagen VI filaments in an Ullrich syndrome patient with loss of the alpha3(VI) N10-N7 domainsSamp1 Mislocalization in Emery-Dreifuss Muscular Dystrophy
P50
Q24309728-927CA755-2EF1-4CFB-AD1A-2D053E6045D3Q28241359-754537F4-197E-40BB-AF22-E607C83A26F9Q28272792-FC70464D-13CE-4D48-B0AE-97C368642AF0Q28541992-1326128A-5396-40DD-9AE3-49606B4B2CADQ28542922-F3DF1149-B303-406C-AF47-971A53E52B13Q34470744-C161E48B-BD48-4610-B53A-244FAA398C07Q34520717-427670FB-BE0A-4A28-8B07-CEAD3AC5E1CEQ35771419-821715FD-385D-4FDC-89E8-FF7F5679ECFDQ36205365-C8336E07-6BD4-4C1E-9729-B7E6955DE44FQ36281672-CF445198-419E-4875-8F18-482996E8F2BBQ36557465-4D97A0CB-B1CE-473E-B04D-E9C857399014Q36753080-3C9DDC97-47BE-421B-BBBB-05C893734E45Q36870797-D8F47472-1739-490C-AF48-7890357E51E3Q37186036-3BB5AFB8-626B-4927-B3FD-74473E1C9363Q37375185-B57ABE56-6E9F-43B1-978C-5C6586374A5BQ38284300-2D2FED74-E906-4B75-9B61-08F3E701B7E1Q38691486-93DABFF6-A679-43B8-94F2-4CDD486EDD13Q38820573-01B464B1-4046-4344-BE2E-0E08195D4B42Q38970616-D9A6E7E8-D25C-4399-A07C-836BD64FF247Q40670845-EDED3667-C207-4D88-92F4-F25EDB68162AQ40879194-874DBDB2-5ADF-4096-B3A8-5FC9B36B5C07Q40979703-43F33469-5BEB-4F65-B9CE-CF170A727657Q42013273-D5819855-D4E2-4BFE-AA41-679EBA3AC64AQ42735850-4BD2F87F-5809-4496-86D8-9F11DF433050Q42815664-6421C219-A138-4E19-B21B-470D393C82FCQ43556782-43BBB8DA-5910-4AED-9D8D-9E5D59C83259Q44661085-10105E0D-39D7-401C-8A34-8ACAE5B1DCCBQ45886040-2FAF2F7C-66D0-428B-B104-086204925A70Q46296157-FC784E08-9453-4322-88C8-9406DC3A6313Q47702766-8252E63B-1031-4148-ABE5-00500DFAC788Q50059432-B5D42C7C-30F6-4503-B6DC-204C809901ADQ52564206-1398ABF1-37A8-4B41-A885-EAC95BC3EE39Q53538268-ECDF3CA6-3120-4B3F-B894-D7F1C4E07E90Q54945496-0A38FB9A-1507-4587-AAC4-7A43DED35106Q56395784-7038FEC8-FE0B-4C18-B685-D186B4A7AB76Q56959042-F363471D-E16D-46D9-BB7E-55F5325EA7F7Q56978882-9D798B2E-45B4-44B5-9DB1-98715E5D774BQ56985192-91E5F307-308C-49B3-AAFC-C156934026A6Q56998901-442380AF-05E2-48D7-9C7F-9DDF5E769CA2Q57461816-11CAC610-0D34-4AFC-BF80-C6E77AA2E0B9
P50
description
researcher
@en
wetenschapper
@nl
name
Marta Columbaro
@en
Marta Columbaro
@es
Marta Columbaro
@nl
type
label
Marta Columbaro
@en
Marta Columbaro
@es
Marta Columbaro
@nl
prefLabel
Marta Columbaro
@en
Marta Columbaro
@es
Marta Columbaro
@nl
P106
P31
P496
0000-0002-4439-8976